Jaimeson Veldhuizen

Jaimeson Veldhuizen has a diverse work experience in the field of scientific research. They started their career as a Flinn Aging and Cognition Scholar at iCAMP, University of Arizona, where they conducted clinical research on the geriatric population and analyzed data collected from sensors to identify impaired cognitive status. They then worked as a Gore Research Scholar at the University of Arizona, utilizing a lung on-a-chip microfluidic device to mimic biological interactions of the alveolar membrane.

After that, Jaimeson served as a Helios Scholar at the Translational Genomics Research Institute (TGen), where they calculated theoretical values and performed experiments on a miniaturized vacuum tube system for a self-administered blood collector. They also interned as a NASA Space Grant Intern at the University of Arizona, establishing a prostate on-a-chip to study cell interactions and training new students in microfluidic chip creation.

Jaimeson's next role was as a Ph.D. Student and RA in the Biomedical Engineering Department at ASU, where they developed a novel heart on-a-chip model and used gene-editing techniques to study the role of a mutation in cardiovascular diseases. They also studied myocardial ischemia and reperfusion injury.

Most recently, Jaimeson worked as a Scientist at Fate Therapeutics Inc, focusing on scientific research. They are currently a Scientist II at Replay since 2023.

Jaimeson Veldhuizen completed a Bachelor's Degree in Biomedical Engineering from the University of Arizona between 2013 and 2017. Following this, Jaimeson pursued further education and obtained a Doctor of Philosophy - PhD degree in Bioengineering and Biomedical Engineering from Arizona State University between 2017 and 2021.